JP Morgan Maintains Neutral on Alkermes, Raises Price Target to $32
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Jessica Fye maintains a Neutral rating on Alkermes (NASDAQ:ALKS) and raises the price target from $31 to $32.
July 25, 2024 | 1:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan analyst Jessica Fye maintains a Neutral rating on Alkermes and raises the price target from $31 to $32.
The raised price target from $31 to $32 indicates a slight positive outlook from JP Morgan, which could lead to a minor uptick in the stock price. However, the Neutral rating suggests limited upside potential.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100